Medication info
Olstech Tablet 20mg (Olmesartan Medoxomil)

Olstech Tablet 20mg (Olmesartan Medoxomil)

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tablet
Manufacturer / importer
Pharmgen Science Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201100869 · Approved 2011.02.22 · Insurance code 670103210

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, the dose may be increased to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at about 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to start treatment at a low dose while monitoring the patient's condition closely. <Elderly patients> No dose adjustment is required when administering this drug to elderly patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and it may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.
Child dose
<Pediatric patients> The safety and efficacy in pediatric patients have not been established.

Ingredients

Manufacturer
Pharmgen Science Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension is a condition treated to control blood pressure within a normal range. This medication helps lower blood pressure by dilating blood vessels and reducing the burden on the heart. Continuous treatment can reduce the risk of cardiovascular complications and improve overall health. Therefore, it is used in the treatment of essential hypertension.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, the dose may be increased to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at about 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to start treatment at a low dose while monitoring the patient's condition closely. <Elderly patients> No dose adjustment is required when administering this drug to elderly patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and it may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.

Child dose

<Pediatric patients> The safety and efficacy in pediatric patients have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Persons with an allergy to this medication or its components, pregnant women, nursing mothers, patients undergoing kidney dialysis, patients with severe liver impairment, patients with bile duct obstruction, and patients with lactose intolerance should not take this medication. Hypotension may occur in patients with decreased blood volume or sodium levels, so their condition should be closely monitored, and appropriate measures should be taken if necessary. Patients with reduced kidney function or who have received a kidney transplant must periodically check kidney function and blood potassium levels through blood tests, and this medication is not recommended for those with severe renal impairment. Patients with hypertension, heart failure, kidney problems, etc., may experience side effects such as worsening of kidney function or hyperkalemia, so caution is needed. Dizziness may occur, so it is advisable to avoid hazardous activities such as working at heights or driving. If taken with other antihypertensive medications, the blood pressure-lowering effect may be increased, and combined use with potassium-sparing diuretics or potassium supplements may lead to dangerously elevated potassium levels in the blood. Concomitant use with lithium preparations can increase lithium concentrations, leading to toxicity; therefore, this combination should be avoided. Caution is required as the use of non-steroidal anti-inflammatory drugs (NSAIDs) may worsen kidney function. Pregnant women should discontinue use to avoid serious impacts on the fetus, and nursing mothers should discontinue breastfeeding or the medication due to the potential for adverse reactions in infants. Safety has not been established for children, so it is advisable not to use this medication in pediatric patients. In case of overdose, hypotension and palpitations may occur, so it is important to consult medical personnel immediately if any unusual symptoms arise. This medication is known to have a low risk of carcinogenicity or genotoxicity with long-term use; however, any unusual symptoms encountered during treatment should be reported to healthcare professionals immediately.

Side effects

Dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly closed container. It is best to maintain the storage temperature between 1 to 25 degrees Celsius to preserve its effectiveness for a long time.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.